TechBio vs. Biotech—what’s real, what’s hype, and how GenAI is actually changing the lab.In this interview, Kavya Sharman, PhD (Founder & Managing Partner, Phase Capital) breaks down the true differences between techbio and biotech,…
Continue Reading
Thomas Kluz, Managing Director at Niterra Ventures
What if the future of drug discovery no longer rests on bold experiments, but on disciplined partnerships where artificial intelligence becomes as indispensable to pharma as the laboratory…
Continue Reading
TandemAI scores $22M for drug discovery platform | MobiHealthNews
Skip to main content…
Continue Reading
Juanita Schoen, Sr. Engagement Manager at Columbus
When most healthcare executives hear about artificial intelligence, they think of drug discovery or clinical trials, but the bigger opportunity is happening behind the scenes. Enterprise resource planning…
Continue Reading
Rare diseases affect over 300 million people worldwide and pose unique research challenges. In silico approaches, such as mechanistic models, machine learning, and simulations, offer scalable tools for disease characterisation, drug discovery, and virtual…
Continue Reading
We're excited to be back for another episode of the Life Sciences Today Podcast by Healthcare IT Today. My guest today is Yann Gaston-Mathé, Co-Founder and CEO at Iktos.Iktos combines AI drug discovery with…
Continue Reading
Iambic secures $100M for drug discovery platform | Mobi Health News
Skip to main content…
Continue Reading
Although still at a nascent state, quantum computing promises advances in healthcare, from drug discovery to personalised treatments. But it also threatens current cryptographic systems that protect medical data and infrastructure. The concept of…
Continue Reading
Artificial Intelligence (AI) is revolutionizing biotechnology by accelerating advancements in drug discovery, genomics, medical imaging, and personalized medicine, thereby enhancing efficiency and reducing healthcare costs. This review emphasizes the transformative potential of multimodal AI—systems…
Continue Reading
Globally, drug discovery and development programs are complex, multi-decade long and prohibitively expensive. Artificial intelligence (AI) and other digital health technologies have the potential to enhance and accelerate each stage of drug discovery and…
Continue Reading
